Injective Near-Term Upside: Target $17.59

I see Injective (INJ) building bullish momentum and targeting $17.59 in the short term — roughly a one-week horizon from the current $14.34 despite a recent 6.34% pullback.

Technical signals (momentum oscillators and recent price structure) favor upside continuation if volume confirms; the decline looks like a corrective dip rather than a trend reversal.

I’d take an opportunistic long stance while using position sizing and a stop below key support to limit downside if momentum fails to sustain.